Momentum Burst Setup?Is this a good example of a momentum burst set up?
The price has made a 4% move today where I have made the buy.
The preceding 3 days have been small range days and in all 3 sessions the market closed below the open i.e. down days.
There has been an orderly consolidation with price moving sidewa
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.40 USD
−127.30 M USD
837.60 M USD
88.14 M
About Myriad Genetics, Inc.
Sector
Industry
CEO
Paul J. Diaz
Website
Headquarters
Salt Lake City
Founded
1991
FIGI
BBG000D9H9F1
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
MYGN second cupFound a cup on this volatile stock. Previous cup made it to the 62% mark which is impressive.
Very weird handle. Seems to be in a broadening pattern and then is in an ascending triangle pattern. I would say wait to break cup top which should be soon.
T1: 38% depth at $39.50 and 62% depth at $44.
MYRIAD GENETICS Chart Hello traders, MYRIAD GENETICS is in a fake bearish configuration with a large buying volume executed and a water carrying candle accompanied by a very strong lower leg. Looking at the TIMEFRAME M1 we see a marubozu with a large negotiated purchase volume, it goes towards the base of the bollinger f
MYGN TankI thought about it and didn't publish this because my earnings plays for today didn't play out like it should have. CENT and USX both lost money but apparently "beat estimates", which is hilarious when the estimate is a loss. You'd think they were tech companies or something. At least CENT went d
Risk Reward, Plenty of Potential vs ProblemsMYGN has been a player for a while, large company, with actual earnings, however litigation and companies are generally a bad thing. "healthy" enough of a chart for me to participate, but I will not have much patience to the downside, stop in place.
**Long this last collapse, limited in size... co
Looking for a Nice Rebound to 31I think this stock will recover some of it's losses, regardless of the outcome of the potential FDA restrictions on drug suggestions. The stock has a solid business model and the company has said they are seeing increased demand. This new fields of genetics testing still needs to establish itself in
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of MYGN is 7.64 USD — it has decreased by −3.41% in the past 24 hours. Watch Myriad Genetics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Myriad Genetics, Inc. stocks are traded under the ticker MYGN.
MYGN stock has fallen by −5.80% compared to the previous week, the month change is a −23.60% fall, over the last year Myriad Genetics, Inc. has showed a −59.85% decrease.
We've gathered analysts' opinions on Myriad Genetics, Inc. future price: according to them, MYGN price has a max estimate of 29.00 USD and a min estimate of 8.00 USD. Watch MYGN chart and read a more detailed Myriad Genetics, Inc. stock forecast: see what analysts think of Myriad Genetics, Inc. and suggest that you do with its stocks.
MYGN reached its all-time high on Nov 6, 2000 with the price of 65.80 USD, and its all-time low was 1.37 USD and was reached on Aug 31, 1998. View more price dynamics on MYGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MYGN stock is 4.62% volatile and has beta coefficient of 0.97. Track Myriad Genetics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Myriad Genetics, Inc. there?
Today Myriad Genetics, Inc. has the market capitalization of 704.19 M, it has decreased by −5.21% over the last week.
Yes, you can track Myriad Genetics, Inc. financials in yearly and quarterly reports right on TradingView.
Myriad Genetics, Inc. is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
MYGN earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0.030 USD resulting in a −1.29% surprise. The estimated earnings for the next quarter are −0.054 USD per share. See more details about Myriad Genetics, Inc. earnings.
Myriad Genetics, Inc. revenue for the last quarter amounts to 210.60 M USD, despite the estimated figure of 211.62 M USD. In the next quarter, revenue is expected to reach 200.56 M USD.
MYGN net income for the last quarter is −42.50 M USD, while the quarter before that showed −22.10 M USD of net income which accounts for −92.31% change. Track more Myriad Genetics, Inc. financial stats to get the full picture.
No, MYGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 2.7 K employees. See our rating of the largest employees — is Myriad Genetics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Myriad Genetics, Inc. EBITDA is −28.30 M USD, and current EBITDA margin is −3.10%. See more stats in Myriad Genetics, Inc. financial statements.
Like other stocks, MYGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Myriad Genetics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Myriad Genetics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Myriad Genetics, Inc. stock shows the sell signal. See more of Myriad Genetics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.